Applikon Biotechnology showing AppliFlex ST and MiniBio at ESACT-UK meeting
Press Release | Applikon Biotechnology B.V.
JANUARY 02, 2019
Delft, The Netherlands: – Dutch-based upstream bioprocess equipment specialist Applikon Biotechnology B.V. (Applikon) will showcase leading edge bioreactor solutions including AppliFlex ST and miniBio at the upcoming annual meeting of the UK arm of the European Society for Animal Cell Technology (ESACT-UK) in the New Year.
3D printed customizable and scalable stirred tank single-use bioreactor
The AppliFlex ST solution uses 3D printing technology to provide a head plate that is uniquely configured to each individual process, including custom impeller design, and different sample port connections.
The Applikon display will also feature the miniBio desktop sized bioreactor that scales down the classic laboratory scale bioreactor with the same versatility and flexibility that allow it to be customized to fit the demands of any cell culture or gene therapy process.
Both solutions will be shown powered up and operational.
Cell culture expertise
“Applikon has maintained a close relationship with ESACT here in the UK, and attended the previous meeting in Leeds,” commented Applikon UK Bioreactor Sales Specialist Tony Borthwick, who will be representing the company at the Drayton Manor meeting, along with Bioreactor Sales Specialist Dan Corcoran.
“This is an excellent event for networking and introducing new products to a highly expert and influential audience of cell culture professionals,’ said Mr. Borthwick.
About Applikon Biotechnology
Netherlands-based Applikon Biotechnology B.V. (Applikon) is a manufacturer that specializes in upstream bioprocess equipment for the life sciences industries. Its mission is to provide reliable solutions for the bioprocess market to enable improved quality of life.
Applikon’s core business is in the development and supply of advanced bioreactor systems from laboratory scale, to pilot, to production scale, partnering with customers to implement scalable platforms from initial screening through development and full-scale production for a global client base that includes pharma and biotech companies, food industry, CROs, CMOs, governmental and academic organizations.
Applikon designs, develops and assembles bioreactor systems, with all design and manufacturing conducted in-house. The Applikon portfolio covers key product and service areas including bioreactor cultivation systems, BioBundle turnkey systems, the unique BioSep Acoustic Perfusion System cell retention device, process control systems to automate bioprocesses and a range of proprietary Applisens sensors, and automation (monitoring and data management) solutions.
Apart from its standard cultivation and turnkey systems, Applikon also offers Special Projects: custom solutions aimed at helping clients fulfil strategic needs such as long-term development, capability expansion and up scaling.
Applikon is headquartered at Delft in The Netherlands with subsidiaries in the UK, New Jersey and California, USA and a distributor network covering more than 35 countries.
About ESACT UK 2019
Based in the United Kingdom, ESACT-UK is a sister of the European Society for Animal Cell Technology (ESACT) as an organization that promotes the communication of knowledge and experience between scientists and engineers whose work has a direct or indirect bearing on cell culture biotechnology and the products derived from it.
ESACT-UK actively encourages interactions between academia, governmental and policy making agencies, and the manufacturing and service industries, such as the international Good Cell Culture Practice (GCCP) Guidance Document.
The 29th annual meeting of ESACT UK is a two-day event opening January 9, 2019 at the Drayton Manor hotel near Tamworth in Staffordshire.
The event is organized by ESACT-UK with further information at: http://www.esactuk.org.uk/index.php/meetings/2019/.
Media Department, Applikon Biotechnology B.V.
Tel: +31 10 208 3555